The COVID-19 pandemic has stretched hospitals to capacity with highly contagious patients. Acute care hospitals around the world have needed to develop ways to conserve dwindling supplies of personal protective equipment (PPE) while front-line clinicians struggle to reduce risk of exposure. By placing intravenous smart pumps (IVSP) outside patient rooms, nurses can more quickly attend to alarms, rate adjustments and bag changes with reduced personal risk and without the delay of donning necessary PPE to enter the room. The lengthy tubing required to place IVSP outside of patient rooms comes with important clinical implications which increase the risk to patient safety for the already error-prone intravenous medication administration process. This article focuses on the implications of increasing medication dead volume as intravenous tubing lengths increase. The use of extended intravenous tubing will lead to higher medication volumes held in the tubing which comes with significant safety implications related to unintended alterations in drug delivery. Safe intravenous medication administration is a collaborative responsibility across the team of nurses, pharmacists and ordering providers. This article discusses the importance and safety implications for each role when dead volume is increased due to IVSP placement outside of patient rooms during the COVID-19 pandemic. No data are available.

中文翻译：

---

在COVID-19期间，将管道延伸以将静脉智能泵放置在病房外：这项创新技术增加了药物死体积和对患者的风险

COVID-19大流行使医院的能力扩展到了具有高度传染性的患者。在前线临床医生努力降低暴露风险的同时，世界各地的急诊医院都需要开发出一些方法来保护日益减少的个人防护设备（PPE）供应。通过将静脉智能泵（IVSP）放置在病房外部，护士可以更快地进行警报，费率调整和行李更换，从而降低了人身风险，并且没有因为穿上必要的PPE而进入病房的情况。将IVSP放置在病房外所需的较长管道具有重要的临床意义，这对于已经很容易出错的静脉药物给药过程增加了患者安全的风险。本文重点介绍随着静脉输液管长度增加，药物死体积增加的含义。使用加长的静脉输液管将导致输液管中容纳的药物量增加，这与药物输送意外更改相关的重大安全隐患。安全的静脉药物管理是护士，药剂师和订购提供者团队之间的协作责任。本文讨论在COVID-19大流行期间因IVSP放置在病房外而导致死体积增加时，每个角色的重要性和安全性。无可用数据。使用加长的静脉输液管将导致输液管中容纳的药物量增加，这与药物输送意外更改相关的重大安全隐患。安全的静脉药物管理是护士，药剂师和订购提供者团队之间的协作责任。本文讨论在COVID-19大流行期间因IVSP放置在病房外而导致死体积增加时，每个角色的重要性和安全性。无可用数据。使用加长的静脉输液管将导致输液管中容纳的药物量增加，这与药物输送意外更改相关的重大安全隐患。安全的静脉药物管理是护士，药剂师和订购提供者团队之间的协作责任。本文讨论在COVID-19大流行期间因IVSP放置在病房外而导致死体积增加时，每个角色的重要性和安全性。无可用数据。本文讨论在COVID-19大流行期间因IVSP放置在病房外而导致死体积增加时，每个角色的重要性和安全性。无可用数据。本文讨论在COVID-19大流行期间因IVSP放置在病房外而导致死体积增加时，每个角色的重要性和安全性。无可用数据。